«Ηπατολογικά προβλήματα σχετιζόμενα με την κατάχρηση οινοπνεύματος»
Δ.Δημητρουλόπουλος, Ε.Πετρουλάκη, Ε.Παρασκευάς, Στο: Κατάχρηση- Εξάρτηση Οινοπνεύματος :κλινικά προβλήματα- θεραπευτική αντιμετώπιση. Εκδόσεις ITACA
Δημοσιεύσεις
Όλες οι δημοσιεύσεις
Peginterferon/ribavirin Treatment Achieve Higher Compliance Rate in Methadone maintenanceChronic HCV infected Patiens Than withInterferon/ribavirin Combination
Dimitris Dimitroulopoulos,Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitris Xinopoulos, KlisthenisTsamakidis, Dimitris Tzourmakliotis, Emmanouil Paraskevas. Gastroenterology April 2005 Volume 128. Number 4. Suppl 2
Peginterferon/ ribavirintreatment achieves a higher compliance rate than interferon/ribavirincombination in patients chronically infected with HCV on methadonemaintenance
Dimitrios Dimitroulopoulos, Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Dimitris Xinopoulos, Klisthenis Tsamakidis, Dimitris Tzourmakliotis, Emmanouil ParaskevasEuropean Journal of Gastroenterology & Hepatology Deceber 2009,Volume 21
Methadone treatment: Hepatitis infection and liver
Mavroides N,Douzenis A, Tsaklakidou D, Petroulaki E, Kokoris C4ο International Meetingof IGSC Organisation, Athens,December 1996
High compliance rate in Methadone maintenance HCV patiens with PegylatedInterferon a Plus Ribavirin than with Interferon a plus Ribavirin combination
Dimitroulopoulos D., Petroulaki E., Manolakopoulos S., AnagnostouO., Tsaklakidou D., Xinopoulos D., Tsamakidis K., Tzourmakliotis D., Paraskevas E.20th World Congress of Gastroenterology, Montreal Canada, 2005
Peginterferon /ribavirin Treatment Achieve Higher Compliance Rate inMethadone maintenance Chronic HCVinfected Patiens Than with Interferon/ribavirin Combination
Dimitris Dimitroulopoulos, Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitris Xinopoulos, Klisthenis Tsamakidis, Dimitris Tzourmakliotis, Emmanouil Paraskevas106th Annual Meeting of the American Gastroenterological Association,Chicago USA,May 2005
AntiHCV treatment outcome in drug users is associatedwith buprenorfine use and adherence totreatment
Anagnostou O1,Tsirogianni E1, Goulis I2, Moursellas A1,Kollia S1, Petroulaki E1, Dimitroulopoulos D3, Micha A1, Manolakopoulos S4
OKANA- Greek Organisation AgainstDrugs, 2Aristoteleion University Of Thessaloniki Medical School,
3 Hellenic Anticancer Institute,”Saint Savvas” Hospital, 4 Athens University Medical School Latent TB infection among injection usersin methadone programs in Greece P.Katsaounou, E.Petroulaki, K.Kougianos, M.Gaggadi,G. Politis ATS May2006
Hepatitis C treatment for intravenous drugusers under substitution in real life
O.Anagnostou, E.Tsirogianni, I.Goulis, S.Kollia, E.Petroulaki, D,Dimitroulopoulos, A.Micha, A.Moursellas, S. Manolakopoulos
OKANA- Greek Organisation Against Drugs, 2 Aristoteleion University Of Thessaloniki Medical School, 3 Hellenic Anticancer Institute, “Saint Savvas” Hospital,
4 Athens University Medical School 1st International Symposium onHepatitis Care in Substance Users September 2009